1887
Volume 2025, Issue 1
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Ventriculoperitoneal shunt (VPS) placement treats hydrocephalus by draining excess cerebrospinal fluid (CSF). Despite advances, infections remain a common complication, resulting in significant morbidity and mortality. Infection rates range from 7.2 to 18%, with common pathogens being and . Risk factors include young age, postoperative CSF leakage, prolonged surgery, and previous infections. The aim of this study was to describe the prevalence of CSF shunt infections at King Abdullah University Hospital (KAUH), assess infection rates in pediatric and adult patients, and report causative microorganisms.

A retrospective analysis was conducted on all patients with CSF shunt-related infections in our hospital (KAUH) over the last 17 years (2005–2023). The patients’ demographics, laboratory results, and details of causative microorganisms were collected.

Of the 579 patients who underwent CSF shunting at KAUH in Jordan, 59 (10.1%) had a positive CSF culture for shunt infection. The majority of the patients were children (83.1%) with a median age of 9 months and a higher proportion of male patients (57.6%). Most of the infections were due to congenital anomalies (74.6%). The median time to infection was 13 days, with 13.5% experiencing recurrent infections. Recurrent infection rates were found to be significantly higher in pediatric patients ( = 0.00007). The most common pathogens were (47.5%) and species (40.7%). Analysis by age group showed a significant association between age and infections ( = 0.008).

The study provided demographic and microbiological data on VPS infections, with being the most common causative organism. Treatment of these infections remains challenging, highlighting the need for more comparative research on different treatment options.

© 2025 Daoud, Hulliel, Jarrar, Jaradat, Jamous, Al Barakat, et al., licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2025.11
2025-02-23
2025-12-14

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/qmj/2025/1/qmj.2025.11.html?itemId=/content/journals/10.5339/qmj.2025.11&mimeType=html&fmt=ahah

References

  1. Paff M, Alexandru-Abrams D, Muhonen M, Loudon W. Ventriculoperitoneal shunt complications: a review. Interdiscip Neurosurg. 2018;13:66–70. doi: 10.1016/j.inat.2018.04.004.
     [Google Scholar]
  2. Renier D, Lacombe J, Pierre-Kahn A, Sainte-Rose C, Hirsch JF. Factors causing acute shunt infection. Computer analysis of 1174 operations. J Neurosurg. 1984 Dec; 61:(6):1072–1078. doi: 10.3171/jns.1984.61.6.1072.
     [Google Scholar]
  3. Piatt JH, Jr., Carlso CV. A search for determinants of cerebrospinal fluid shunt survival: retrospective analysis of a 14-year institutional experience. Pediatr Neurosurg. 1993 Sep–Oct; 19:(5):233–241; discussion 242. doi: 10.1159/000120738.
     [Google Scholar]
  4. Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg. 2001 Feb; 94:(2):195–201. doi: 10.3171/jns.2001.94.2.0195.
     [Google Scholar]
  5. Rotim K, Miklic P, Paladino J, Melada A, Marcikic M, Scap M. Reducing the incidence of infection in pediatric cerebrospinal fluid shunt operations. Childs Nerv Syst. 1997 Nov–Dec; 13:(11–12):584–587. doi: 10.1007/s003810050144.
     [Google Scholar]
  6. Campbell D, Sinclair S, Cooke D, Webster D, Reid M. The incidence of VP shunt infection in a middle-income nation: a retrospective analysis of a pediatric population. Front Surg. 2023 Dec 20;10:1304105. doi: 10.3389/fsurg.2023.1304105.
     [Google Scholar]
  7. Ayogu OM, Igbokwe KK, Jabir KM, Onobun ED, Okpata CI, Ugwuanyi U, et al. Ventriculoperitoneal shunt infection rate and other associated complications of VP shunt insertion in Abuja, Nigeria. World Neurosurg X. 2024 Mar 2:23:100332. doi: 10.1016/j.wnsx.2024.100332.
     [Google Scholar]
  8. Kanev PM, Sheehan JM. Reflections on shunt infection. Pediatr Neurosurg. 2003 Dec; 39:(6):285–290. doi: 10.1159/000075255.
     [Google Scholar]
  9. McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis. 2003 Apr 1; 36:(7):858–862. doi: 10.1086/368191.
     [Google Scholar]
  10. Sacar S, Turgut H, Toprak S, Cirak B, Coskun E, Yilmaz O, et al. A retrospective study of central nervous system shunt infections diagnosed in a university hospital during a 4-year period. BMC Infect Dis. 2006 Mar 8:6:43. doi: 10.1186/1471-2334-6-43.
     [Google Scholar]
  11. Raygor KP, Oh T, Hwang JY, Phelps RRL, Ghoussaini K, Wong P, et al. Ventriculoperitoneal shunt infection rates using a standard surgical technique, including topical and intraventricular vancomycin: the Children's Hospital Oakland experience. J Neurosurg Pediatr. 2020 Jul 24; 26:(5):504–512. doi: 10.3171/2020.4.PEDS209.
     [Google Scholar]
  12. Lee JK, Seok JY, Lee JH, Choi EH, Phi JH, Kim SK, et al. Incidence and risk factors of ventriculoperitoneal shunt infections in children: a study of 333 consecutive shunts in 6 years. J Korean Med Sci. 2012 Dec; 27:(12):1563–1568. doi: 10.3346/jkms.2012.27.12.1563.
     [Google Scholar]
  13. Simon TD, Hall M, Riva-Cambrin J, Albert JE, Jeffries HE, Lafleur B, et al. Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article. J Neurosurg Pediatr. 2009 Aug; 4:(2):156–165. doi: 10.3171/2009.3.PEDS08215.
     [Google Scholar]
  14. McGirt MJ, Leveque JC, Wellons J3rd, Villavicencio AT, Hopkins JS, Fuchs HE, et al. Cerebrospinal fluid shunt survival and etiology of failures: a seven-year institutional experience. Pediatr Neurosurg. 2002 May; 36:(5):248–255. doi: 10.1159/000058428.
     [Google Scholar]
  15. Vinchon M, Dhellemmes P. Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Childs Nerv Syst. 2006 Jul; 22:(7):692–697. doi: 10.1007/s00381-005-0037-8.
     [Google Scholar]
  16. Borgbjerg BM, Gjerris F, Albeck MJ, Børgesen SE. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien). 1995; 136:(1–2):1–7. doi: 10.1007/BF01411427.
     [Google Scholar]
  17. Schoenbaum SC, Gardner P, Shillito J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis. 1975 May; 131:(5):543–552. doi: 10.1093/infdis/131.5.543.
     [Google Scholar]
  18. Prusseit J, Simon M, von der Brelie C, Heep A, Molitor E, Volz S, et al. Epidemiology, prevention and management of ventriculoperitoneal shunt infections in children. Pediatr Neurosurg. 2009; 45:(5):325–336. doi: 10.1159/000257520.
     [Google Scholar]
  19. Reddy GK, Bollam P, Caldito G. Ventriculoperitoneal shunt surgery and the risk of shunt infection in patients with hydrocephalus: long-term single institution experience. World Neurosurg. 2012 Jul; 78:(1–2):155–163. doi: 10.1016/j.wneu.2011.10.034.
     [Google Scholar]
  20. Mullan E, Lucas C, Mackie S, Carachi R. Audit of ventriculoperitoneal shunt infections in paediatric patients, 2006–2013. Scott Med J. 2014 Nov; 59:(4):198–203. doi: 10.1177/0036933014548665.
     [Google Scholar]
  21. Wang KW, Chang WN, Shih TY, Huang CR, Tsai NW, Chang CS, et al. Infection of cerebrospinal fluid shunts: causative pathogens, clinical features, and outcomes. Jpn J Infect Dis. 2004 Apr; 57:(2):44–48.
     [Google Scholar]
  22. Thadtapong N, Chaturongakul S, Soodvilai S, Dubbs P. Colistin and carbapenem-resistant Acinetobacter baumannii Aci46 in Thailand: genome analysis and antibiotic resistance profiling. Antibiotics (Basel). 2021 Aug 30; 10:(9):1054. doi: 10.3390/antibiotics10091054.
     [Google Scholar]
  23. Novović K, Jovčić B. Colistin resistance in Acinetobacter baumannii: molecular mechanisms and epidemiology. Antibiotics (Basel). 2023 Mar 4; 12:(3):516. doi: 10.3390/antibiotics12030516.
     [Google Scholar]
  24. Gedefie A, Alemayehu E, Mohammed O, Bambo GM, Kebede SS, Kebede B. Prevalence of biofilm producing Acinetobacter baumannii clinical isolates: a systematic review and meta-analysis. PLoS One. 2023 Nov 30; 18:(11):e0287211. doi: 10.1371/journal.pone.0287211.
     [Google Scholar]
  25. Agarwal N, Shukla RM, Agarwal D, Gupta K, Luthra R, Gupta J, et al. Pediatric ventriculoperitoneal shunts and their complications: an analysis. J Indian Assoc Pediatr Surg. 2017 Jul–Sep; 22:(3):155–157. doi: 10.4103/0971-9261.207624.
     [Google Scholar]
  26. Erps A, Roth J, Constantini S, Lerner-Geva L, Grisaru-Soen G. Risk factors and epidemiology of pediatric ventriculoperitoneal shunt infection. Pediatr Int. 2018 Dec; 60:(12):1056–1061. doi: 10.1111/ped.13709.
     [Google Scholar]
  27. Tuan TJ, Thorell EA, Hamblett NM, Kestle JR, Rosenfeld M, Simon TD. Treatment and microbiology of repeated cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J. 2011 Sep; 30:(9):731–735. doi: 10.1097/INF.0b013e318218ac0e.
     [Google Scholar]
/content/journals/10.5339/qmj.2025.11
Loading
Investigating the types of microorganisms causing cerebrospinal fluid shunt infection in King Abdullah University Hospital in Jordan
Qatar Medical Journal 2025, 11 (2025); https://doi.org/10.5339/qmj.2025.11
/content/journals/10.5339/qmj.2025.11
/content/journals/10.5339/qmj.2025.11
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): Acinetobacter baumannii, coagulase-negative staphylococci and Ventriculoperitoneal shunt

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error